Another lncRNA, CASC2, acts as a tumor suppressor in human malignancies, serving as a ceRNA for miR-183 and positively amplifying the expression of another tumor suppressor, SPRY2, a key antagonist of receptor tyrosine kinase signaling. The gene discussed is SPRY2; the disease is neoplasm.